Viewing Study NCT01235260


Ignite Creation Date: 2025-12-25 @ 2:06 AM
Ignite Modification Date: 2025-12-26 @ 6:57 PM
Study NCT ID: NCT01235260
Status: COMPLETED
Last Update Posted: 2016-07-19
First Post: 2010-11-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Becaplermin Use and Cancer Risk in a Patient Population of U.S. Veterans With Diabetes
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module